Drug-induced acute kidney injury (AKI) is often encountered in hospitalized patients. Although serum creatinine (SCr) is still routinely used for assessing AKI, it is known to be insensitive and nonspecific. Therefore, our objective was to evaluate kidney injury molecule 1 (KIM-1) in conjunction with microRNA (miR)-21, -200c, and -423 as urinary biomarkers for drug-induced AKI in humans.
INTRODUCTION
Acute Kidney Injury (AKI) affects 1 in 5 hospitalized patients worldwide (Susantitaphong et al., 2013) . A substantial proportion of AKI is attributed to drug-induced kidney injury (DIKI): 18-27% in hospitalized individuals with AKI (Taber and Pasko, 2008; Uchino et al., 2005) . Furthermore, nephrotoxicity is a common reason for drug development failure both in the preclinical and clinical stages. In clinical settings, AKI is assessed by measurement of functional biomarkers like serum creatinine (SCr) that is known to have low sensitivity, specificity, and limited capability for early diagnosis (Vaidya et al., 2008) . A delayed diagnosis hinders not only timely care of AKI patients but also prevents stratification of AKI patients for clinical trials of AKI treatment; therefore, there is an urgent need for new kidney injury biomarkers with improved characteristics.
In 2008, seven urinary protein biomarkers were amongst the first batch qualified by the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA, 2009) for the assessment of DIKI in preclinical studies. Although these biomarkers, like Kidney injury molecule-1 (KIM-1), outperformed traditional biomarkers in sensitivity and specificity in preclinical studies, successful regulatory qualification and implementation into clinical practice are still awaited (Dieterle and Sistare, 2010; Jensen, 2004; Murray et al., 2014) . Another class of biomarkers that have recently emerged as promising candidates for detection of diverse cancer types, organ damages and other disease states are extracellular microRNAs (miRNAs) found stable in diverse body fluids and resistant to RNase-mediated degradation, pH variability and multiple freeze-thaw cycles (McDonald et al., 2011; Mitchell et al., 2008; Mraz et al., 2009; Weber et al., 2010) . MiRNAs are approximately 20-25 nucleotides long, non-coding and evolutionarily conserved small RNAs that function intracellularly as post-transcriptional regulators of gene expression by binding to complementary sequences in the 3'-untranslated regions of target mRNAs (Krol et al., 2010) . Our group described the methodology and application for the use of urinary miRNAs to differentiate AKI patients from healthy individuals (Ramachandran et al., 2013; Saikumar et al., 2012) . In particular, we found urinary levels of miR-21, miR-200c and miR-423 exhibited significantly high sensitivity and specificity in differentiating AKI patients admitted in the intensive care unit vs. patients with no evidence of AKI (Ramachandran, et al., 2013) .
The objective here was to evaluate the performance of for detecting drug-induced AKI in humans. Specifically the aims were: 1) to measure urinary KIM-1, miR-21, miR-200c and miR-423 in a cross-sectional cohort of patients (n=135) with acetaminophen (APAP) overdose and in a longitudinal cohort of patients (n=108) with malignant mesothelioma receiving cytoreductive surgery with intraoperative cisplatin therapy; 2) to identify the source of the miRNAs by performing in situ hybridization in human kidney sections and by conducting in vitro experiments using human proximal tubular epithelial cells following toxicity; and 3) to computationally predict the targets for the three candidate miRNAs and highlight the possibility of urinary miRNA profiles to reflect pathological events in the kidney. (pg/ml) were normalized to urinary creatinine (UCr; mg/dl) to account for dilution effects of the hydration status and are reported as urinary levels in pg/mg UCr.
In vitro Experiments
Human proximal tubular epithelial cells (HPTECs) which are passaged cells derived from normal human kidney tissue were purchased from Biopredic International (Rennes, France).
Previously, we have shown that HPTECs possess characteristics of differentiated epithelial cells, such as polar architecture, junctional assembly, expression and activity of transporters, ability to synthesize enzymes like glutathione and γ-glutamyl transferase all up to passage 4 (Adler, et al., 2015) . Thus we consider them to be not only primary cells but also better than the immortalized cells derived from human (HK2), dog (MDCK) and pig (LLCPK1) in terms of mimicking human kidney tubular epithelial structure and function. The cells were cultured in DMEM/Hams-F12 with GlutaMAX medium supplemented with 100 IU/ml penicillin, 100 µg/ml streptomycin, 36 ng/ml hydrocortisone, 10 ng/m epidermal growth factor, 1% insulin-transferrinselenium and 4 pg/ml triiodothyronin on collagen coated tissue culture plates at 37°C in a humidified 5% CO 2 incubator. Cp and 4-aminophenol (Sigma-Aldrich; Saint Louis, MO) were diluted in medium with 0.5% DMSO with final concentrations of 10 µM to 1000 µM for doseresponse experiments in 96-well plates. After 24h cell viability was measured by Cell-Titer Glow assays (Promega; Madison, WI) and dose-response curves were generated using GraphPad 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Prism 6 (GraphPad Software Inc.; La Jolla, CA). Calculated LD 50 values correspond to previously published for these compounds and cells (Adler, et al., 2015) . For measurement of miRNAs in medium and in the cells itself, HPTECs were seeded in 6-well plates and treated with 85 and 100 µM Cp and 4-aminophenol, concentrations selected based on previously published LD 50 values. After 24h of treatment, medium was removed, centrifuged twice (10 min 1,600xg then 10 min 16,000xg) and the resulting supernatant as well as the corresponding cells were used for total RNA isolation.
RNA Isolation and Measurement of miRNAs
RNA isolation: 200 µl urinary supernatant was used for isolation with the miRNeasy Serum/Plasma Kit from Qiagen (Valencia, CA) according to manufacturer's instructions. Total RNA form 200 µl medium supernatant and HPTECs was isolated with the miRNeasy Mini Kit (Qiagen). Quality and quantity of the cellular RNA war assessed photometrically using a NanoDrop 8000 (Thermo Scientific; Wilmington, DE).
Reverse transcription (RT) and Pre-Amplification: 1.5 µl of the eluted RNA (urinary and medium supernatant) or 10 ng cellular RNA were revers transcribed into cDNA using Qiagen's miScript RTII kit. The prepared cDNA was diluted five-fold and 5 µl of the diluted cDNA was then preamplified with Qiagen's miScript PreAMP kit for urinary and medium samples. The pre-amplified cDNA was diluted five-fold prior to qPCR detection.
qPCR: For urine samples, candidate miRNA evaluation was performed using custom 384-well plates preloaded with specific primer probes for miR-21, -200c and -423 from Qiagen. For medium and cellular miRNAs same assays were used. This SYBR Green-based qPCR was performed according to manufacturer's instructions with 2 µl diluted and pre-amplified cDNA in a total reaction volume of 10 µl. The thermal profile was as following: activation 15 sec at 95°C; 40 cycles of annealing/elongation with 15 sec at 94°C, 30 sec at 60°C and 30 sec at 72°C.
Finally, a melt curve analysis war included. For urine samples, the Ct of the positive qPCR ).
In situ Hybridization
Kidney biopsy samples were fixed in neutral buffered formalin, trimmed and paraffin embedded followed by sectioning of the tissue block into approximately 5 µm thick sections. Standard H&E staining was used to assess the degree of injury. In situ hybridization was performed using AAAGTCTCGCTCTCTGCCCCTCA, Tm 94°C, 60 nM) were incubated for one hour 30°C below the RNA melting temperature which corresponds to the optimal hybridization temperature.
Nuclear Fast Red TM was used for counter staining (Sigma-Aldrich). Finally, sections were analyzed by light microscopy.
Target analysis
Ingenuity Pathway Analysis (IPA, Ingenuity® Systems, www.ingenuity.com) was employed to search for target mRNAs containing sequences complementary to those present in the miRNAs (so-called miRNA target analysis for identification of mRNAs potentially regulated by miRNAs) and for pathway analysis in general. The two following filter criteria were applied for target analysis: 1.) experimentally observed and/or highly predicted target relation, i.e. sequence complementarity between mRNA and miRNA, and 2.) known expression in the kidney. The final group of identified miRNA targets was further investigated with IPA's Core Analysis to find associated pathways and diseases.
Statistical analysis
Urinary levels of miRNAs and KIM-1 are expressed as median and interquartile range with 5 th and 95 th percentiles as whiskers. Statistical significance was calculated with log2 urinary levels by t-test considering a p-value cut-off adjusted for multiple comparisons (significant in APAP study: p<0.004; significant in Cp study: p<0.0014) using GraphPad Prism 6 (GraphPad Software Inc., CA). Logistic regression models were used to evaluate associations of all three candidate miRNA biomarkers as well as KIM-1 with the odds of AKI, and to estimate area under the receiver operator curve (AUC-ROC). Regression models were adjusted for age and sex.
Spearman correlation analysis (ρ and corresponding p-value) was performed to assess correlation between all biomarkers using data from all patients at all time points. Statistical analyses were performed using Stata 13.0 (StataCorp, College Station, TX). 
RESULTS

Detection of APAP-induced AKI in a cross-sectional study using KIM-1 and candidate miRNAs
Three groups of patients, 43 with APAP overdose and AKI and 27 without a clinical diagnosis of AKI, as well as 65 healthy volunteers were enrolled in the cross-sectional study (Table 1) . Since APAP is primarily a liver toxicant, all APAP-overdosed (OD) patients had liver injury diagnosed by ~100-fold increased levels of alanine aminotransferase as compared to healthy volunteers (Table 1) . Urinary levels of KIM-1, miR-21, -200c, and -423 were significantly (adjusted p-value cutoff: p<0.004) higher in both APAP-OD patients with AKI compared to healthy controls and in APAP-OD patients without AKI diagnosis compared to healthy controls (Figure1A and B).
Among patients with APAP-OD, higher urinary concentrations of each biomarker were associated with higher odds of AKI (Table 2) (Table 2) .
Performance of KIM-1 and candidate miRNAs in a longitudinal study of Cp-induced AKI
To evaluate early diagnostic and predictive capabilities we next measured candidate miRNAs and KIM-1 in a longitudinal cohort of patients (n=106) with mesothelioma undergoing cytoreductive surgery with intraoperative Cp before and after Cp administration (Table 3) . , and 423 were high in mesothelioma patients at baseline before Cp-treatment as compared to levels from healthy, non-cancer patients from the APAP study (Suppl. Figure 1) .
After Cp treatment, we found that miR-21, -200c, -423 as well as KIM-1 significantly increased 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 (adjusted p-value cutoff: p<0.0014) in urine compared to levels before the treatment with each biomarker being high in patients with AKI diagnosis but also in patients without clinically proven AKI (Figure 2 ). At any given time point, however, none of the biomarkers were significantly different between patients with and without AKI and concentrations of biomarkers were not associated with the odds of AKI (Table 4 ). All miRNAs correlated highly with each other, whereas the correlation of miRNAs was weak with KIM-1 SCr. The correlation of KIM-1 with SCr was also weak (Table 5) .
Expression patterns of miR-21, -200c and -423 in the human kidney
In an attempt to investigate the expression patterns of the candidate miRNAs in human kidney 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 decreased after Cp treatment ( Figure 4C ). The increase in medium not only mimics the in vivo findings and strengthens the hypothesis of kidney proximal tubular epithelial cells to be the source for miR-21, -200c and -423 releases in urine after kidney toxicity but also demonstrates the utility of these candidate miRNAs for screening nephrotoxic agents in vitro.
Mechanistic implication of miR-21, -200c and -423
MiRNAs function as intracellular regulators of gene expression, thus we hypothesized that the urinary miRNA profile might reflect affected pathways in the injured kidney. To test this hypothesis, Ingenuity Pathway Analysis (IPA) was used to find mRNA targets for miR-21, -200c
and -423. In total, 1102 mRNA targets were identified mostly associated with pathways also known to be perturbed in different pathological conditions in the kidney ( Figure 5A ). The top pathway and associated pathological condition was found to be MYC-mediated apoptosis signaling and renal necrosis/cell death, respectively. In addition, a deeper insight into the targets associated with renal necrosis/cell death as major feature of AKI, revealed that miR-21, -200c
and -423 have several overlapping targets including genes well-known in apoptosis like cyclindependent kinase inhibitor 1 (CDKN1A, p21) or B-cell lymphoma 2 (Bcl-2) ( Figure 5B ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
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DISCUSSION
Using a multi-dimensional approach to examine the association of candidate biomarkers with drug-induced AKI, we evaluated urinary KIM-1, miR-21, -200c and -423 among AKI patients, enrolled in a cross-sectional as well as longitudinal study. All four biomarkers were higher in patients with APAP overdose, relative to healthy subjects and were highest among patients with APAP overdose and diagnosed AKI. In longitudinal analyses, all biomarkers were elevated post Cp treatment, regardless of future AKI status.
The poor performance of urinary miRNAs and KIM-1 to predict AKI may reflect the inadequacy of a SCr-based definition for AKI (Waikar et al., 2012) . Although in preclinical studies renal histopathological examination is the gold standard for AKI diagnosis, in clinical assessments SCr remains widely used. In fact, moderate performances of new AKI biomarker candidates are frequently seen in clinical studies, where AKI is mostly defined based on increased SCr levels (Vanmassenhove et al., 2013) . Several studies have demonstrated that patients who were SCr negative but biomarker positive are at risk for short-as well as long term morbidity and mortality (Coca et al., 2014; Haase et al., 2011) . Haase et al. (2012) suggested to term this condition subclinical AKI, because it is not clinically detectable with existing routine diagnostics (SCr, blood urea nitrogen) however, tubular damage markers such as KIM-1 and NGAL suggest injury (Haase et al., 2012) .
In a preclinical study, both miR-21 and KIM-1 accurately reflected AKI diagnosed by histopathology but not when diagnosed by SCr (Suppl. Figure 2 ; Pavkovic et al., 2014 and 2015) . In clinical settings renal biopsies are not readily available, thus the evaluation of novel biomarkers becomes hindered by the inadequacy of SCr-based definitions of the outcome.
Finding a solution to this paradox in clinical AKI biomarker evaluation is challenging. However, in the case of drug-induced AKI, the treatment with the nephrotoxic drug per se can be used for comparison. Our results confirmed previous reports that KIM-1 has high sensitivity and specificity for tubular injury. A meta-analysis including data from 2979 patients concluded that urinary KIM-1 may be a promising biomarker for early detection of AKI also in clinical settings (Shao et al., 2014) . A recently published study using a very small number of patients (n=22) with solid tumors receiving Cp treatment showed a comparable increase of KIM-1 in urine after treatment, as seen here, whereas SCr was not increased (Tekce et al., 2015) . The exploration of KIM-1's function revealed interesting features involved in phagocytosis and regeneration (Ichimura et al., 2008; Yang et al., 2015) , but limited information was added to the mechanism of initiation of AKI.
In contrast, miRNAs bear the potential to fill this gap since it is estimated that over 50% of all protein-coding genes are regulated by miRNAs (Krol, et al., 2010) . Applying Ingenuity Pathway
Analysis for the three candidate miRNAs studied here, the top pathological kidney conditions found to be associated with the targets was renal necrosis highlighting the previously mentioned possibility of urinary miRNA profiles to mirror molecular perturbations in the kidney. MiR-21 has been extensively explored since it is ubiquitously expressed in mammalian organs; it is enriched in the kidney where it is involved in diverse physiological as well as pathophysiological processes (Landgraf et al., 2007; Ma and Qu, 2013) . In the context of AKI, miR-21 is described as a negative regulator in the apoptosis of tubular epithelial cells but also as involved in progression of fibrosis via SMADs after TGFβ activation (Li et al., 2013) . In a mouse model of Alport nephropathy it was shown that since miR-21 is further involved in metabolism and FA oxidation, inhibition of miR-21 probably enhanced PPARα/RXR activity and improved mitochondrial function. Thus it was deemed protective against TGF-β-induced fibrogenesis and inflammation in kidneys (Gomez et al., 2015) . MiR-200c has been mainly investigated in the context of cancer where it was found to regulate epithelial-mesenchymal transition via downregulation of ZEB1 and AKT resulting in an upregulation of E-cadherin (Bracken et al., 2015; Wang et al., 2013) . In addition, miR-200c is involved in cell growth and cell cycle 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 progression by suppressing the expression of CDK2 in renal carcinoma cell lines and xenografts (Wang et al., 2015) . MiR-423 has been less well-studied but has been shown to increase proliferation and cell growth by targeting Trefoil factor 1 and p21 in gastric and hepatocellular cancer, respectively (Lin et al., 2011; Liu et al., 2014) . Furthermore, miR-423 is part of a miRNA signature associated with lupus nephritis (Te et al., 2010) . Overall, target prediction analysis and current knowledge about the function of the three miRNAs support our hypothesis of urinary miRNAs profiles as reflection of intrarenal processes.
Using human kidney biopsy samples, miR-423 was found expressed in the whole kidney cortex i.e. in tubular and glomerular structures whereas miR-200c could not be detected and miR-21 seemed to be expressed in injured areas of the kidney from patients with ATN. An expression in normal human kidneys was shown previously for miR-21 and -200c using PCR (Bao et al., 2014) , thus the lack of detection here could be due to the low technical sensitivity of in situ hybridization. Expression of all three miRNAs was detected in HPTECs. For miR-21, contrary to the in situ hybridization results, decreased expression was seen in HPTECs after treatment with Cp. This discrepancy could be due to the in vitro system per se or the different kind of AKI (ATN after allograft rejection) in the kidney biopsy samples. However, we found all three miRNAs increased in cell medium after Cp or 4-AP treatment, probably mimicking the in vivo situation.
Our study has several limitations. First, the longitudinal cohort consisted of patients with malignant mesothelioma. As such, an impact of concomitant cancer, rather than the Cptreatment per se, on the miRNA profile in urine cannot be excluded. In fact, miR-21 expression in cancerous tissue was described as part of a 6-miRNA signature to predict survival in patients with malignant mesothelioma (Kirschner et al., 2015) . A direct comparison of all biomarker profiles in urine from both studies demonstrated high levels of miR-21, -200c and -423 in cancer patients (Suppl. Figure 1) . Second, miRNA candidates were selected based on a crosssectional discovery approach with healthy volunteers vs. AKI patients from the intensive care unit having different etiologies. Since AKI is a clinical condition with various etiologies the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 existence of one single, universal AKI biomarker seems unlikely. A more focused discovery approach using a case-control cohort of patients with drug-induced kidney toxicity has the potential to yield more sensitive and specific biomarkers for drug-induced AKI.
In summary, we show that KIM-1 along with miR-21, -200c and -423 can be non-invasive as well as specific urinary biomarkers for the detection of drug-induced AKI in patients. Based on their kidney expression and target analysis, miR-21, -200c, and -423 could add information about the affected molecular pathways in the kidney during AKI. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 Table with absolute levels as medians (interquartile range) of arbitrary miRNA levels (x10
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; 2 -∆Ct normalized by urinary creatinine) or absolute KIM-1 concentration (pg/mg urinary creatinine).
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